Taking BRCA as an example, previous researchers have demonstrated through in vivo and in vitro experiments that knockdown of OPA1 expression can reduce proliferation migration and invasion of breast cancer cells, and OPA1 silencing can increase miRNA levels of the 148/152 family that inhibit tumor growth and invasion. Here, OPA1 is linked to breast cancer.